|

Fecal Microbiota Transplantation Clinical Trials

5 actively recruiting trials across 1 location

No change since August 2026

Also known as: (PRIM-DJ2727), Colonoscopy, FMT

Pipeline

Early 1: 1Phase 2: 3

Top Sponsors

  • Wang Xin1
  • University Hospital, Clermont-Ferrand1
  • Second Xiangya Hospital of Central South University1
  • M.D. Anderson Cancer Center1
  • Air Force Military Medical University, China1

Indications

  • Cancer3
  • Liver Disease2
  • Refractory Hepatic Encephalopathy1
  • Fecal Microbiota Transplantation1
  • Hepatic Encephalopathy1

Other4 trials

Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
Phase 2
Fecal Microbiota Transplantation for the Treatment of Refractory Hepatic Encephalopathy After TIPS Surgery
Early 1
PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy
Phase 2
Safety and Efficacy of Fecal Microbiota Transplantation on Cognitive Function in T1DM
N/A

Houston, Texas1 trial

Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.

MD Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.